GHK-Cu: Clinical Guide for Prescribing Practices
GHK-Cu is a naturally occurring copper peptide found in human plasma, saliva, and urine. It declines with age and has been studied for its effects on collagen synthesis, wound healing, skin remodeling, and anti-inflammatory activity. It is popular in both aesthetic medicine and anti-aging protocols.
Also Known As
How GHK-Cu Works
GHK-Cu functions as a copper delivery vehicle that activates tissue remodeling genes, including those responsible for collagen synthesis, glycosaminoglycan production, and metalloproteinase regulation [1]. The tripeptide binds copper(II) ions with high affinity and stimulates decorin expression, which organizes collagen fibrils during wound repair [1]. It also modulates TGF-beta signaling and suppresses pro-inflammatory cytokines (IL-6, TNF-alpha), enabling coordinated tissue regeneration [2].
Clinical Evidence
Pickart et al. demonstrated that GHK-Cu accelerates wound contraction and stimulates collagen synthesis in animal models, with subsequent studies confirming upregulation of over 4,000 human genes related to tissue repair [1][2]. A 2015 gene expression study showed GHK-Cu restores gene expression patterns to a healthier, more youthful state in fibroblasts [3]. Clinical studies of topical GHK-Cu formulations have demonstrated increased collagen density, reduced fine lines, and improved wound healing in dermatologic settings [4]. The peptide's decline from approximately 200 ng/mL in plasma at age 20 to 80 ng/mL by age 60 provides a rationale for supplementation in aging populations [2].
Clinical Uses
Patient Selection and Screening
Ideal candidates include patients seeking non-surgical facial rejuvenation, those with chronic wounds or post-procedural healing needs, and individuals on systemic anti-aging protocols [3]. GHK-Cu is contraindicated in patients with Wilson's disease or other copper metabolism disorders. Patients with active liver disease should have copper levels assessed prior to initiation. Combining injectable and topical formulations can address both local and systemic anti-aging goals [4].
Dosing and Administration
Subcutaneous injection dosing is typically 1 to 2 mg daily or every other day for systemic anti-aging protocols, administered in 4 to 8 week cycles [1]. Topical formulations (creams and serums) are applied once or twice daily at concentrations of 1 to 3% for facial rejuvenation and wound healing [4]. Injectable protocols may be combined with topical application for synergistic local and systemic effects. Cycling (4 weeks on, 2 weeks off) is commonly employed, though long-term continuous topical use is generally well tolerated [3].
Route: Subcutaneous injection, topical
Protocol notes: Available as subcutaneous injection, topical cream, or serum. Route depends on clinical indication.
Side Effects and Monitoring
Clinical Considerations
Practice Economics
GHK-Cu spans both aesthetic and wellness revenue streams, appealing to med spas, dermatology practices, and anti-aging clinics alike [3]. Topical formulations offer high-margin retail product sales alongside injectable treatment protocols [4]. The dual application (cosmetic plus systemic anti-aging) creates multiple billing opportunities per patient and supports subscription or membership models for ongoing skin care protocols.
FDA Category Status
Expected to return to Category 1 per February 2026 HHS announcement
FDA bulk drug substance category determines compounding eligibility. Category designations are subject to change; always verify the current status before prescribing. This information is provided for clinical reference and does not constitute legal or regulatory advice.
Pharmacy Integrations
Prescribe GHK-Cu through Karpa's integrated compounding pharmacy network with one-click ordering and direct-to-patient fulfillment.
Frequently Asked Questions
Is GHK-Cu only used topically?
Which practice types commonly offer GHK-Cu?
References
- Pickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. 2008;19(8):969-88.
- Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987.
- Pickart L et al. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. Biomed Res Int. 2015;2015:648108.
- Abdulghani AA et al. Effects of topical creams containing vitamin C, a copper-binding peptide cream and melatonin compared with tretinoin on the ultrastructure of normal skin. Disease Management and Clinical Outcomes. 1998;1(4):136-41.
Disclaimer: This information is intended for licensed healthcare providers only and does not constitute medical, legal, or regulatory advice. Clinical decisions should be based on your professional judgment, current evidence, and applicable state and federal regulations. Always verify FDA category status and compounding eligibility before prescribing. Content is reviewed periodically but may not reflect the most recent regulatory changes.
Prescribe GHK-Cu Through Karpa
Streamline your peptide prescribing workflow with integrated pharmacy ordering, patient tracking, and compliance documentation.
Prescribe GHK-Cu Through Karpa